NeuroVive Pharmaceutical AB: Interim Report 1 Jan. 2013 till 31 Mar. 2013
5/28/2013 8:28:17 AM
Staying up-to-date has never been simpler. Sign up for the free GenePool newsletter today!
The listing on Nasdaq OMX creates possibilities for the future
“After NeuroVive’s IPO on NASDAQ OMX Stockholm Small Cap in April, the company has secured prospects for its continued work in its priority business segments relating to CicloMulsion®and NeuroSTAT®.”
Help employers find you! Check out all the jobs and post your resume.